In vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugs
- 18 July 2008
- journal article
- Published by Wiley in Medical Mycology
- Vol. 37 (6) , 405-409
- https://doi.org/10.1111/j.1365-280x.1999.00245.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Significance of fungal evolution for the understanding of their pathogenicity, illustrated with agents of phaeohyphomycosisMycoses, 1997
- Treatment of chromoblastomycosis with itraconazole, cryosurgery, and a combination of bothInternational Journal of Dermatology, 1997
- Therapie von Infektionen durch SchwärzepilzeMycoses, 1997
- Treatment of chromomycosis with terbinafine: preliminary results of an open pilot studyBritish Journal of Dermatology, 1996
- Treatment of tropical mycosesJournal of the American Academy of Dermatology, 1994
- Dihydroxynaphthalene (DHN) Melanin and Its Relationship with Virulence in the Early Stages of PhaeohyphomycosisPublished by Springer Nature ,1991
- Chromoblastomycosis Treated by Mohs Micrographic SurgeryThe Journal of Dermatologic Surgery and Oncology, 1986
- Antifungal drug susceptibility testingMycopathologia, 1984
- Treatment of chromomycosis with ketoconazole and 5-fluorocytosineJournal of the American Academy of Dermatology, 1983
- Chromoblastomycosis and phaeohyphomycosis: New concepts, diagnosis, and mycologyJournal of the American Academy of Dermatology, 1983